Human Umbilical Cord Mesenchymal Stem Cell Therapy (19#iSCLife®-CI) for Cerebral Infarction Patients in Convalescent Period.

NCT03176498 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

SUSPENDED

Status

40

Enrollment

INDUSTRY

Sponsor class

Stopped Others

Conditions

Cerebral Infarction

Interventions

BIOLOGICAL: Allogeneic umbilical cord mesenchymal stem cell
DRUG: Aspirin Enteric-coated Tablets & Atorvastatin Calcium

Sponsor

Sclnow Biotechnology Co., Ltd.